[HTML][HTML] Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
W Ouyang, J Yu, Y Zhou, J Hu, Z Huang, J Zhang… - BMC cancer, 2020 - Springer
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
[HTML][HTML] Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
W Ouyang, J Yu, Y Zhou, J Hu, J Zhang, C Xie - BMC Cancer, 2020 - ncbi.nlm.nih.gov
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
Risk Factors of Metachronous Brain Metastasis in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
W Ouyang, J Yu, Y Zhou, J Hu, Z Huang, J Zhang… - 2020 - researchsquare.com
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.
W Ouyang, J Yu, Y Zhou, J Hu, J Zhang, C Xie - BMC Cancer, 2020 - go.gale.com
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
[HTML][HTML] Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
W Ouyang, J Yu, Y Zhou, J Hu, J Zhang… - BMC …, 2020 - bmccancer.biomedcentral.com
NSCLC patients with EGFR mutation were at a higher incidence of developing brain
metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.
W Ouyang, J Yu, Y Zhou, J Hu, J Zhang, C Xie - BMC Cancer, 2020 - search.ebscohost.com
Background: NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
[PDF][PDF] Risk Factors of Metachronous Brain Metastasis in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
W Ouyang, J Yu, Y Zhou, J Hu, Z Huang, J Zhang… - scholar.archive.org
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
W Ouyang, J Yu, Y Zhou, J Hu, Z Huang… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer
W Ouyang, J Yu, Y Zhou, J Hu, J Zhang, C Xie - BMC Cancer, 2020 - search.proquest.com
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
Risk factors of metachronous brain metastasis in patients with EGFR-mutated advanced non-small cell lung cancer.
W Ouyang, J Yu, Y Zhou, J Hu, Z Huang, J Zhang… - BMC Cancer, 2020 - europepmc.org
Background NSCLC patients with EGFR mutation were at a higher incidence of developing
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …
brain metastasis (BM). Patients with BM are associated with high mortality. Reducing BM …